Dr. Roy Wins WE-REACH Go-To-Market Award for Novel Drug to Treat Idiopathic Pulmonary Fibrosis (IPF)
The Washington Entrepreneurial Research Evaluation and Commercialization Hub (WE-REACH) is pleased to announce a product…
dcorriganMay 5, 2022
Read about local recipients of life science grants, awards, fellowships, and scholarships.